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There is no agreement which outcomes should be measured when investigating interven-
tions for periodontal diseases. It is difficult to compare or combine studies with different out-
comes; resulting in research wastage and uncertainty for patients and healthcare
professionals.
Objective
Develop a core outcome set (COS) relevant to key stakeholders for use in effectiveness tri-
als investigating prevention and management of periodontal diseases.
Methods
Mixed method study involving literature review; online Delphi Study; and face-to-face con-
sensus meeting.
Participants
Key stakeholders: patients, dentists, hygienist/therapists, periodontists, researchers.
Results
The literature review identified 37 unique outcomes. Delphi round 1: 20 patients and 51 den-
tal professional and researchers prioritised 25 and suggested an additional 11 outcomes.
Delphi round 2: from the resulting 36 outcomes, 13 patients and 39 dental professionals and
researchers prioritised 22 outcomes. A face-to-face consensus meeting was hosted in Dun-
dee, Scotland by an independent chair. Eight patients and six dental professional and
researchers participated. The final COS contains: Probing depths, Quality of life, Quantified
levels of gingivitis, Quantified levels of plaque, Tooth loss.
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Conclusions
Implementation of this COS will ensure the results of future effectiveness trials for periodon-
tal diseases are more relevant to patients and dental professionals, reducing research wast-
age. This could reduce uncertainty for patients and dental professionals by ensuring the
evidence used to inform their choices is meaningful to them. It could also strengthen the




Periodontal diseases are inflammatory diseases that affect the soft and hard tissues supporting
teeth or ‘the periodontium’. Periodontal diseases are largely preventable, yet remain one of the
major causes of poor oral health worldwide and is the primary cause of tooth loss in older
adults [1–4]. Periodontal diseases share common risk factors with other chronic diseases and
conditions, such as obesity, heart disease, stroke, cancer, chronic obstructive pulmonary dis-
ease and diabetes [5–10].
Several interventions for the prevention and management of periodontal diseases are only
supported by low quality evidence [11–14]. There is a wide variety of outcomes and clinical
indices reported in trials. This outcome heterogeneity has been highlighted in guidance docu-
ments as well as Cochrane systematic reviews [13, 15–20]
It can be difficult to compare or combine studies if different outcomes are investigated and
reported. This results in research wastage as these trials cannot fully contribute to improved
decision making for patients and dental professionals [21, 22].
There is currently no agreement (amongst dental professionals or patients) as to which out-
comes should be measured when investigating interventions for periodontal diseases.
The COMET (Core Outcome Measures in Effectiveness Trials) initiative [23] develops core
outcome sets (COS), that are defined as an agreed, standardised collection of outcomes which
should be measured and reported in all effectiveness trials for a specific clinical area or inter-
vention. Core outcome sets represent the minimum that should be measured and reported
upon in all trials. All relevant stakeholders should be involved in the development of a COS; it
is important that patients say what outcomes matter most to them. The COS development pro-
cess is concerned about what outcomes should be measured, not how these outcomes are
measured.
A COS for periodontal diseases will establish through consensus a minimum list of out-
comes that are relevant to patients and clinicians to be used in future effectiveness trials. This
will reduce future research waste and improve care.
We aimed to develop a core outcome set for effectiveness trials investigating interventions
for periodontal diseases. This COS would not be limited by health status, age or clinical
setting.
Methods
The development of this COS followed best practice and involved three stages: (1) Identifica-
tion of existing outcomes; (2) Filling in gaps in knowledge and prioritisation of outcomes
using Delphi survey; and (3) Face-to-face consensus meeting to finalise COS. The methods for
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each stage are outlined in detail below and in Fig 1. The study was registered on the COMET
database [24]. The study protocol was developed and published in an open access peer
reviewed BMC Trials journal [25]. Our report is in accordance with recommendations of the
Core Outcome Set-STAndards for Reporting (COS-STAR) checklist [21].
Ethical approval and protocol registration
Ethical approval was granted by the University of Dundee Schools of Nursing and Health Sci-
ences and Dentistry Research Ethics Committee (Ref: 2016028_Lamont). Informed consent
was obtained from all participants when they opted in to participate in the e-Delphi process.
Participants of the face-to-face consensus meeting provided written consent.
Stage 1: Identification of existing outcomes
To identify existing outcome domains in the literature we searched the Cochrane database of
systematic reviews for relevant published reviews and protocols investigating the prevention
Fig 1. Flow diagram overview of overall core outcome set development.
https://doi.org/10.1371/journal.pone.0254123.g001
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and treatment of periodontal diseases. The search was conducted up to July 2016. From the
reviews and protocols that met our inclusion criteria we recorded the type of intervention(s),
outcome measures (clinical, patient and economic) and duration of follow-up. We extracted
data from all the trials within the included reviews and recorded any additional outcomes and
indices reported by these trials that were not reported by the review. Different trials used vari-
ous terminologies for the same outcome; these were de-duplicated to produce a list of unique
outcomes. The outcomes were categorised as clinical; person-centred or economic. The lead
investigator, Thomas James Lamont (TJL) independently extracted the data and the results
were randomly reviewed by a second investigator (Jan Clarkson). Results were tabulated using
Microsoft Excel (Microsoft Corporation, Redmond, WA).
Stage 2: Filling in gaps in knowledge and prioritising outcomes
The e-Delphi process used the COMET initiative Delphi Manager [26] which is an online plat-
form that facilitates the Delphi process.
Participants were allocated into two stakeholder groups: (1) Patients and (2) Dental profes-
sionals and researchers. There is no commonly accepted methodology for sample size calcula-
tions for e-Delphi studies [26]. The e-Delphi group size does not depend on statistical power
but dynamics of reaching consensus; the literature recommends at least 10–18 per group [27,
28]. For appropriate representation we aimed to recruit approximately 20 patient participants
and 50 dental professionals and researchers initially to ensure that over 50 of these participants
completed the study.
Patient participant recruitment to this study was facilitated by SHARE–the Scottish Health
Research Register. Inclusion criteria for patient participants:�18 years old, literate with access
to the internet and willing to take part. There were no absolute exclusion criteria. SHARE con-
tacted potential participants via telephone enquiries and email invitations. Potential partici-
pants were also provided with a study information sheet providing project goals and
methodology (S1 Appendix).
To ensure representation of the dental profession and researchers multiple recruitment
strategies were utilised for this broad stakeholder group. Dental hygienists, dental therapists,
general dental practitioners, periodontists, restorative consultants, clinical academics,
researchers and public health dentists were all considered potential participants. The British
Society of Periodontology, Scottish Dental Practice Based Research Network and The Royal
Odonto-Chirurgical Society of Scotland circulated a study invitation (including study infor-
mation) to their members. The British Society of Dental Hygiene and Therapy and the Scottish
Dental Practice Based Research Network advertised the study on their websites and members
of the Faculty of General Dental Practitioners (Scotland) and The Glasgow Odontological
Society were informed about the study.
To reduce dropout rates between rounds of the e-Delphi potential participants were asked
to contact the lead researcher (TJL) to demonstrate a willingness to take part in the study. This
initial stage is thought to identify those potential participants that would actively participate in
the process, rather than passively participate.
Round 1. The outcomes were presented by domain (clinical, patient-orientated, eco-
nomic) in alphabetical order. Participants were asked to score each outcome from this list
using the scale proposed by the GRADE group [29], in which 1 to 3 signifies an outcome of
limited importance, 4 to 6 important but not critical, and 7 to 9 critical. Participants were
asked to suggest any outcomes they considered relevant but missing from the list of outcomes.
A minimum of two participants had to propose an outcome for it to be included in the next
round of the process. Reminders were sent to those potential participants who had recorded
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an interest in the study but not completed the survey. Additional outcomes were subsequently
de-duplicated and harmonized with the rest of the list prior to round 2.
Data were extracted from the DelphiManager software and analysed in Microsoft Excel.
For each outcome, the percentage of participants scoring each category of “not important at
all”, “important but not critical” and “very important or critical” was calculated. Those partici-
pants that did not rate an outcome or chose “N/A” did not count towards the denominator in
calculating the percentage of participants rating each category. Descriptive statistics were cal-
culated for each outcome by stakeholder group.
‘Stability of opinions’ for stakeholder groups and individual participants were calculated as
post-hoc analyses. For stakeholder groups this was assessed by computing mean stakeholder
scores for each outcome between rounds; a larger number would represent a potentially
important change in opinion. At the individual level mean change in scores was assessed
between rounds for each individual participant across all outcomes [30].
Responses were summarised by stakeholder groups: (1) patient participants and (2) all
other participants. We specified in advance that to be retained in the second round of the e-
Delphi process, outcomes required 50% or more of the respondents in either stakeholder
group to score it 7 to 9 and fewer than 15% score it as 1 to 3.
Round 2. Participants completing round 1 were invited to round 2 and reminded of their
own scores for each outcome. They were also informed of the percentage of individuals from
each stakeholder group that rated scores 1 through to 9 for each outcome.
Participants were invited to rescore each outcome remaining in the e-Delphi process and
score any additional outcomes that were introduced following the round 1 suggestions.
For the second round of consensus, 70% or more of the respondents in both groups had to
score the remaining outcome’s inclusion as critical (7 to 9) and fewer than 15% as not impor-
tant (1 to 3).
Stage 3: Consensus meeting
All participants of the e-Delphi process were invited to register their interest in attending the
face-to-face consensus meeting. We employed a pragmatic recruitment approach to ensure
adequate patient and dental professional participation by advertising the meeting locally via
patient volunteer groups and staff emails. The inclusion criteria were the same as the e-Delphi
process, namely over 18 years old and willingness to participate in the process.
The face-to-face consensus meeting utilised a modified Nominal Group Technique meeting
design as the idea generation or identifying existing knowledge and fillings gaps in knowledge
stages had already taken place. The priority of the meeting was finalising the recommended
core outcome set.
Although definitive evidence is lacking, a review of nominal groups recommended that
group sizes should remain small, no more than 14 participants, as prioritisation and consensus
can be more difficult to achieve with larger groups [31, 32].
The consensus meeting was facilitated by an independent chair, Dr Katie Gillies (KG)
from the Health Service Research Unit who has experience in mixed-methods research and
Nominal Group Technique meetings. The meeting started with an introduction, overview
of the core outcome set development process, discussion of ground rules and written con-
sent. To encourage group discussion and sharing of views the participants were divided
into two smaller groups with representation of both stakeholder groups in each. Partici-
pants were assigned to one of two tables and each group had a facilitator (KG and TJL)
whose role was to clarify any issues and ensure all participants were able to voice their
views.
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The groups were provided with the list of outcomes from the e-Delphi process. The partici-
pants were given 60 minutes to discuss the outcomes and identify the ‘top 10’ outcomes they
felt should be considered further. Following this first discussion stage participants were given a
short break during which TJL and KG identified prioritised outcomes common to both
groups. These common outcomes would be automatically taken through to the next stage.
Any remaining outcomes identified by one of the groups as important would be discussed and
whole group consensus of the ‘top 10’ outcomes established.
The groups were brought together to discuss the remaining outcomes. Participants were
asked to vote yes/no if they thought the outcome in question should be included in the core
outcome set for effectiveness trials investigating the prevention and management of periodon-
tal diseases. Descriptive statistics were calculated for each of top 10 outcomes voted on by the
stakeholders. The pre-specified agreement criteria for reaching consensus was 70% of all par-
ticipants agreeing that an outcome should be included in the final set. The number of out-
comes to be included in the final set was not pre-specified.
Results
Stage 1: Identification of existing outcomes
Eight Cochrane systematic reviews and three protocols were included from the 194 reviews
and protocols published by Cochrane Oral Health (S1 Table). The predetermined primary and
secondary outcomes of these Cochrane reviews and protocol were collated (S2 Table). The
published Cochrane reviews included 134 unique studies and 23,276 unique participants. Fol-
lowing de-duplication of the outcomes that Cochrane review authors stated they would inves-
tigate, 25 unique outcomes were identified from the eight reviews and three protocols (S3
Table). An additional 12 outcomes were identified from the included trials of six of the pub-
lished Cochrane reviews (S4 Table). The flow diagram of the identification of existing out-
comes is presented in Fig 2). The long list of outcomes is presented in Table 1.
Stage 2: Filling in gaps and prioritising outcomes
Recruitment of dental professionals commenced on the 13 November 2017 by email invitation
to the British Society of Periodontology members. Patient recruitment was commenced by
SHARE on the 15 November 2017. Recruitment continued until the close of round one on the
19 December 2017 at which point the recruitment target had been met.
Round 1. 49 potential patient participants agreed to be sent a formal invitation to the trial.
A total of 61 dental professionals and researchers contacted to express interest in taking part in
the study. From this, 22 patient participants and 51 dental professional and researchers regis-
tered to take part in the study; with 20 and 51 (respectively) actually completing round 1. The
demographics of participants are presented in Table 2. Taken from stage 1, 37 outcomes were
included in round 1 of the e-Delphi process. From this 12 outcomes were excluded as less than
50% of both stakeholder groups scored those outcomes as critical (7–9).
A total of 68 suggestions of missing outcomes were provided by 28 dental professional and
research participants. Following de-duplication 11 separate outcomes met the inclusion crite-
ria of more than two participants recommending it as a new outcome (S5 Table). Combining
these 11 additional outcomes to the 25 outcomes meeting the consensus criteria of round 1
resulted in 36 unique outcomes being taken forward to round 2.
Round 2. Round 2 was open from the 9 to 29 January 2018. A total of 52 participants (13
patients and 39 dental professionals and researchers) completed both round 1 and round 2. 14
outcomes were excluded as less than 70% of participants scored these outcomes as critical (7–
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9). Two of the patient participants reported that they struggled to fully understand or contextu-
lise the outcomes.
There was very little change in the mean scores of each stakeholder groups and individuals
between rounds, the so called ‘stability of stakeholder opinions’ (S6 and S7 Tables). As the
scores for each stakeholder group and individuals remained largely stable it was questionable
whether the feedback had any influence at all and it was unlikely that an additional round
would further improve consensus. Therefore, the Delphi was stopped after two rounds. The 22
unique outcomes taken forward to the face-to-face consensus meeting are summarised in
Table 3.
Stage 3: Consensus meeting
The meeting was hosted in Dundee Dental Education Centre, Scotland on 19 April 2018 and
facilitated by KG. The lead researcher (TJL), was present throughout the meeting to provide
clarification on the study purpose, scope or outcomes included.
A total of 14 participants attended (eight patients and six dental professional and
researcher). Six of these participants had been involved in the e-Delphi process (one patient
and five dental professionals and researchers). The participants involved in the periodontal
core outcome set meeting worked well together, actively seeking and considering different
opinions. The participants worked together to explain the outcomes to one another as they
were discussed. It is likely that the patient participants would have struggled to fully under-
stand outcome definitions or implications without the dental professionals’ explanation. One
example of this is during the discussion on the ‘smoking status’ outcome, when patient partici-
pant E stated: “I think we’ve got to be guided, as non-professionals we’ve got to be guided by
our professionals in respect to smoking”.
Fig 2. Flow diagram of identification of existing outcomes.
https://doi.org/10.1371/journal.pone.0254123.g002
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The results of the prioritisation of the final 22 outcomes are summarised in Table 3. At the
face-to-face consensus meeting the participants discussed the final 22 outcomes and prioritised
their ‘top 10’ outcomes. The participants discussed these outcomes in greater detail and were
asked to vote yes/no if they thought the outcome in question should be included in the core
outcome set for effectiveness trials investigating the prevention and management of periodon-
tal diseases (S8 Table). The final COS contains 5 outcomes: Probing depths, Quality of life,
Quantified levels of gingivitis, Quantified levels of plaque, Tooth loss (Table 4).





Clinical attachment loss Clinical
Compliance Clinical
Dental caries Clinical
Dental crown failure Clinical
Halitosis Clinical
Incidence of periodontitis Clinical
Intra-crevicular exudate Clinical





Quantified levels of gingivitis Clinical
Quantified levels of plaque Clinical
Recession Clinical




Wear of toothbrushes Clinical
Analgesics required Patient reported
Average pain scores Patient reported
Changes in taste perception Patient reported
Patient reported behaviour change Patient reported
Patient reported change in knowledge Patient reported
Patient reported health Patient reported
Quality of life Patient reported
Reliability Patient reported
Satisfaction with actual care received Patient reported
Satisfaction with appearance Patient reported
Satisfaction with product Patient reported
Satisfaction with provider of care Patient reported
Self-efficacy beliefs Patient reported
Cost Economic
Unique outcomes and domains
https://doi.org/10.1371/journal.pone.0254123.t001
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Discussion
This is the first core outcome set developed for periodontology that involved patients, dental
professionals and researchers. Although Core Outcome Sets have been developed widely
across healthcare, their development in Dentistry and Oral health is not as established. There
are however a small number developed or in progress across dentistry [33–35].
The need for the standardisation of meaningful periodontal outcomes and clinical indices
has been a topic of discussion in the periodontal community [16, 20, 36]. The wide variety of
outcomes and clinical indices combined with their uncertain clinical significance for patients
and dental professionals has been acknowledged. This study provides a set of core outcomes
that have been prioritised by patients, dental professionals and researchers.
The participants rated outcomes that had previously been reported in the periodontal litera-
ture for trials investigating the prevention and management of periodontal diseases as well as
those suggested by participants of this study. The online e-Delphi process was chosen to facili-
tate this consensus building process as this was considered the most efficient and pragmatic
study design to prioritise outcomes prior to a face-to-face consensus meeting to finalise the
core outcome set [26, 37, 38]. The design allowed stakeholders from a variety of settings, geo-
graphical and professional backgrounds to consider the importance of the existing outcomes
and suggest missing outcomes.
Table 2. Demographics of participants of e-Delphi study and consensus meeting.
Patients Round 1 survey N = 20 Round 2 survey N = 13 Consensus meeting N = 14
Male, N (%) 9 (45) 4 (31) 3 (38%)
Age range, N (%)
18–30 0 (0) 0 (0) Not recorded
31–45 5 (25) 2 (15) Not recorded
46–70 14 (70) 10 (77) Not recorded
>70 1 (5) 1 (8) Not recorded
Residence Scotland, N (%) 20 (100) 13 (100) 8 (100)
Dental Professionals and researchers Round 1 survey N = 51 Round 2 survey N = 39 Consensus meeting N = 14
Male, N (%) 33 (65) 25 (64) 3 (50)
Age range, N (%)
18–30 5 (10) 5 (13) Not recorded
31–45 19 (37) 16 (41) Not recorded
46–70 26 (51) 18 (46) Not recorded
>70 1 (2) 0 (0) Not recorded
Professional role
Clinical academic 7 (14) 6 (15) 1 (17)
Dental hygienist 4 (8) 2 (5) 1 (17)
Dental therapist 2 (4) 2 (5) 0 (0)
General dental practitioner 11 (22) 9 (23) 1 (17)
Periodontist 14 (27) 9 (23) 1 (17)
Researcher 5 (10) 4 (10) 0 (0)
Restorative consultant 8 (16) 7 (18) 2 (32)
Residence
UK 49 (96) 38 (97) 6 (100)
EU 1 (2) 1 (3) 0 (0)
Non-EU 1 (2) 0 (0) 0 (0)
Demographics of participants in consensus study
https://doi.org/10.1371/journal.pone.0254123.t002
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The face-to-face consensus meeting was the first to bring together these key oral health
stakeholders to discuss what outcomes they consider important for periodontal diseases. The
study design was chosen to achieve consensus on what outcomes should be included in the
core outcome set by facilitating group discussion and mutual clarification of opinions between
the stakeholder groups [37, 39].
The scope of the study (both interventions and health area) was deliberately broad consid-
ering outcomes for all trials that investigate the prevention and management of periodontal
diseases in effectiveness trials. Prevention and management strategies for periodontal diseases
have wide overlap and are not commonly considered in isolation. Periodontal care routinely
involves a multi-faceted approach and therefore it was considered prudent to develop one
Table 3. Final 22 outcomes taken forward to consensus meeting (in alphabetical order).
Outcome Dental Professionals and
researchers round 2 scores
Patient group round 2
scores
Final discussion following consensus meeting voting
1–3 4–6 7–9 1–3 4–6 7–9
Abrasion 59% 38% 3% 0% 18% 82% OUT
Bone levels on radiographic examination 3% 24% 74% 0% 44% 56% OUT
Calculus 3% 46% 51% 0% 25% 75% OUT
Clinical attachment loss 0% 10% 90% 0% 11% 89% OUT
Compliance 3% 0% 97% 0% 25% 75% OUT
Dental caries 15% 67% 18% 0% 17% 83% OUT
Endodontic status 8% 63% 29% 0% 13% 88% OUT
Functional occlusion 14% 54% 32% 0% 0% 100% OUT
Furcation Involvement 3% 37% 61% 0% 25% 75% OUT
Incidence of periodontitis 0% 5% 95% 0% 25% 75% OUT
Intra-crevicular exudate 5% 62% 32% 0% 11% 89% OUT
Manual dexterity 23% 41% 36% 0% 20% 80% OUT
Oral infection 8% 44% 47% 0% 8% 92% OUT
Probing depths 0% 8% 92% 0% 20% 80% IN
Quality of life 0% 28% 72% 0% 15% 85% IN
Quantified levels of gingivitis 0% 18% 82% 0% 25% 75% IN
Quantified levels of plaque 3% 10% 87% 0% 17% 83% IN
Recession 5% 61% 34% 0% 27% 73% OUT
Smoking status 3% 10% 87% 0% 30% 70% OUT
Tooth loss 0% 26% 74% 0% 0% 100% IN
Tooth migration 11% 49% 41% 0% 30% 70% OUT
Tooth mobility 3% 24% 74% 0% 20% 80% OUT
Breakdown of participants scores for the final 22 outcomes taken forward to the face-to-face consensus meeting.
https://doi.org/10.1371/journal.pone.0254123.t003




Quantified levels of gingivitis
Quantified levels of plaque
Tooth loss
Outcomes included in core outcome set
https://doi.org/10.1371/journal.pone.0254123.t004
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single COS for prevention and management strategies due to this wide overlap [12, 40, 41].
The core outcome set was not limited by health statues, age or clinical setting.
Asking participants to suggest any outcomes missing from the initial list provided an
important opportunity to capture outcomes that have not previously been reported in the
Cochrane systematic review literature and in doing so identifying potential gaps in knowledge.
A strength of the study was that it allowed all participants to contribute their opinions.
Throughout the Delphi process each participant rated their opinion of the importance of each
outcome. The participants involved in the consensus meeting worked well together, with
patient and dental professionals actively seeking and considering differing opinions. Bringing
different stakeholder groups together at one face to face meeting resulted in a deeper partici-
pant understanding of the issues, allowing each participant to fully contribute.
The final COS outcomes were all considered ‘critical’ for inclusion by over 70% of both
stakeholder groups of the e-Delphi process. All five outcomes were reported as outcomes that
would have been included in the relevant Cochrane systematic reviews. The outcomes ‘Prob-
ing depths’, ‘Quantified levels of gingivitis’ and ‘Quantified levels of plaque’ had also been
reported in 14%, 81% and 84% of the included studies presented in this outcome literature
review respectively. However, ‘Quality of life’ and ‘Tooth loss’ had not been reported in the
studies.
Potential limitations of the e-Delphi study are the sample size and the loss to follow. There
is no commonly accepted methodology for sample size calculations for e-Delphi studies [26].
We took a pragmatic approach to selecting sample size and the number of participants (51 par-
ticipants completing both rounds) is similar to other e-Delphi studies conducted whilst devel-
oping core outcome sets [42, 43]. There was also loss to follow-up in both groups, with 7 (35%)
and 12 (24%) of patients and dental professionals and researchers respectively not completing
the second round. With 20 patient participants at baseline a lost to follow up of 35% has the
potential to cause large variation within this group across rounds, especially as some partici-
pants rated outcomes as ‘Not applicable’ and therefore did not contribute to the scores of that
outcome. The loss to follow up is similar to other e-Dephi Studies [43, 44] and is considered
one of the main drawbacks of this research design. As stated previously the stakeholder opin-
ions were stable across the rounds and it is likely that the participants that completed both
rounds were able to represent patients at large in prioritising which outcomes continue to the
next phase of the COS development.
It is clear that not all of the participants fully understood the outcomes included in e-Delphi
study. A study information leaflet providing information on study aims was provided to every
participant and tailored to each stakeholder group. It is unclear whether this information was
not sufficiently clear or whether its length put participants off reading it. Various drafts of the
information sheet were produced and piloted on members of the public. The balance between
too much information, which could be off-putting for some, and insufficient information
would be different for various participants. All participants were advised at the start of the pro-
cess that they could contact the study lead (TJL) for clarification but none of the participants
did so.
The main objective of the e-Delphi was to provide participants an opportunity to recom-
mend additional outcomes and to prioritise outcomes to be taken forward to the face to face
meeting. This objective was met by our recruited participants.
Another potential limitation is the lack of anonymity during voting which may have influ-
enced the voting. Previous studies have used anonymous voting to reduce the risk of peer pres-
sure, voting contamination or artificial consensus [37, 45]. Hand or ballet voting as used here
has previously been used successfully in other studies [31, 46].
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All of the face-to-face consensus meeting participants, and the vast majority of those
involved in the delphi study are based in the UK. Although this is a potential limitation, the tri-
als in the Cochrane reviews have been published by research teams from across the world. The
wider generalisability of patient perspectives to the rest of the world is unclear. A number of
the professional participants are active members of the British Society of Periodontology and
have been involved in international meetings and consensus exercises. It is unlikely that dental
professional and researchers opinions from those involved in the study would vary largely
from international colleagues.
Conclusions
Our study reported on the robust development of a COS for use in effectiveness trials investi-
gating prevention and management of periodontal diseases. We propose that the outcomes of:
‘Probing depths’, ‘Quantified levels of gingivitis’, ‘Quantified levels of plaque’, ‘Quality of life’
and ‘Tooth loss’ should be considered the minimum set of outcomes that should be reported
by all effectiveness trials investigating the prevention and management of periodontal diseases.
Implementation of this COS will ensure the results of future effectiveness trials for periodontal
diseases are more relevant to patients, dental professionals and researchers. This could reduce
uncertainty for patients and dental professionals by ensuring the evidence used to inform their
choices is meaningful to them. It could also strengthen the quality and certainty of the evi-
dence about the relative effectiveness of interventions. Future work should focus on how these
outcomes should be measured in practice, as recommended by the Consensus-based standards
for the selection of health Measurement Instruments (COSMIN) initiative [47].
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